Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients
Open Access
- 4 September 2013
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 13 (9) , 2411-2417
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Anogenital Malignancies in Women After Renal Transplantation Over 40 Years in a Single CenterTransplantation, 2012
- Gene expression profile in the liver of Rana catesbeiana tadpoles exposed to low temperature in the presence of thyroid hormoneBiochemical and Biophysical Research Communications, 2012
- Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 yearsHuman Vaccines, 2011
- Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipientsWorld Journal of Surgical Oncology, 2011
- Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2011
- (Pre)malignancies of the Female Anogenital Tract in Renal Transplant RecipientsTransplantation, 2011
- Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years OldJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Human papillomavirus infection and anal dysplasia in renal transplant recipientsBritish Journal of Surgery, 2010
- Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18Virology, 2004
- Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex AssayClinical and Vaccine Immunology, 2003